Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

被引:0
|
作者
Alexander T. Cohen
Janvi Sah
Amol D. Dhamane
Theodore Lee
Lisa Rosenblatt
Patrick Hlavacek
Birol Emir
Allison Keshishian
Huseyin Yuce
Xuemei Luo
机构
[1] King’s College London,Department of Hematological Medicine, Guy’s and St Thomas’ Hospitals, Guy’s and St Thomas’ NHS Foundation Trust
[2] STATinMED Research,New York City College of Technology
[3] Bristol Myers Squibb Company,undefined
[4] Pfizer,undefined
[5] City University of New York,undefined
[6] Pfizer,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Apixaban; Medicare; Race; Socioeconomic status; Venous thromboembolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5519 / 5533
页数:14
相关论文
共 50 条
  • [1] Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. ADVANCES IN THERAPY, 2021, 38 (11) : 5519 - 5533
  • [2] Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Dietrich, Eric
    Lo-Ciganic, Wei-Hsuan
    Park, Haesuk
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (03) : 188 - 195
  • [3] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1940 - 1940
  • [4] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1941 - 1941
  • [5] SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM
    Weycker, Derek
    Li, Xiaoyan
    Wygant, Gail
    Lee, Theodore
    Hamilton, Melissa
    Luo, Xuemei
    Vo, Lien
    Mardekian, Jack
    Pan, Xianying
    Burns, Leah
    Atwood, Mark
    Cohen, Alexander
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1953 - 1953
  • [6] Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Delinger, Rachel
    Yuce, Huseyin
    Luo, Xuemei
    [J]. THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 926 - 938
  • [7] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    [J]. PLOS ONE, 2022, 17 (09):
  • [8] COMPARATIVE EFFECTIVENESS OF APIXABAN VERSUS WARFARIN FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM AND CARDIOVASCULAR DISEASES IN PATIENTS WITH VENOUS THROMBOEMBOLISM
    Dawwas, G.
    Dietrich, E.
    Park, H.
    [J]. VALUE IN HEALTH, 2018, 21 : S57 - S57
  • [9] Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in US Clinical Practice
    Weycker, Derek
    Li, Xiaoyan
    Wygant, Gail DeVecchis
    Lee, Theodore
    Hamilton, Melissa
    Luo, Xuemei
    Vo, Lien
    Mardekian, Jack
    Pan, Xianying
    Burns, Leah
    Atwood, Mark
    Hanau, Ahuva
    Cohen, Alexander T.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2018, 118 (11) : 1951 - 1961
  • [10] Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
    Craig I. Coleman
    Alexander G. G. Turpie
    Thomas J. Bunz
    Jan Beyer-Westendorf
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 339 - 345